DE3314142A1 - Mittel zur behandlung von myokardinfarkt - Google Patents

Mittel zur behandlung von myokardinfarkt

Info

Publication number
DE3314142A1
DE3314142A1 DE19833314142 DE3314142A DE3314142A1 DE 3314142 A1 DE3314142 A1 DE 3314142A1 DE 19833314142 DE19833314142 DE 19833314142 DE 3314142 A DE3314142 A DE 3314142A DE 3314142 A1 DE3314142 A1 DE 3314142A1
Authority
DE
Germany
Prior art keywords
preparation
active ingredient
treatment
myocardial infarction
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19833314142
Other languages
German (de)
English (en)
Other versions
DE3314142C2 (cg-RX-API-DMAC7.html
Inventor
Evgenij Ivanovič Čazov
Valerij Nikolaevič Čicharev
Michail Isaevič Moskva Šmarian
Zinaida Ivanovna Ermakova
Anna Nikitična Gricenko
Ekaterina Kliment'evna Grigorieva
Natalija Venjaminovna Moskva Kaverina
Aleksandra Maksimovna Moskovskaja oblast Krylova
Georgij Fridrichovič Riga Kumerov
Valentin Viktorovič Lyskovcev
Il'mar Char'evič Riga Penke
Natalija Tichonovna Prjanišnikova
Leonid Valentinovič Rozenštrauch
Zlata Petrovna Senova
Aleksandr Petrovič Skoldinov
Artur Viktorovič Val'dman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NII FARMAKOL AKAD MED
VSESOJUZNYJ KARDIOLOGITSCHES
Original Assignee
NII FARMAKOL AKAD MED
VSESOJUZNYJ KARDIOLOGITSCHES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NII FARMAKOL AKAD MED, VSESOJUZNYJ KARDIOLOGITSCHES filed Critical NII FARMAKOL AKAD MED
Priority to DE19833314142 priority Critical patent/DE3314142A1/de
Publication of DE3314142A1 publication Critical patent/DE3314142A1/de
Application granted granted Critical
Publication of DE3314142C2 publication Critical patent/DE3314142C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/30—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19833314142 1983-04-19 1983-04-19 Mittel zur behandlung von myokardinfarkt Granted DE3314142A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19833314142 DE3314142A1 (de) 1983-04-19 1983-04-19 Mittel zur behandlung von myokardinfarkt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833314142 DE3314142A1 (de) 1983-04-19 1983-04-19 Mittel zur behandlung von myokardinfarkt

Publications (2)

Publication Number Publication Date
DE3314142A1 true DE3314142A1 (de) 1984-10-25
DE3314142C2 DE3314142C2 (cg-RX-API-DMAC7.html) 1988-10-27

Family

ID=6196774

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833314142 Granted DE3314142A1 (de) 1983-04-19 1983-04-19 Mittel zur behandlung von myokardinfarkt

Country Status (1)

Country Link
DE (1) DE3314142A1 (cg-RX-API-DMAC7.html)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chem. Abstr., Vol.96, Nr.5, S.45, 28437d, 1982 *
Chem. Abstr., Vol.97, Nr.19, S.58, 156198j, 1982 *

Also Published As

Publication number Publication date
DE3314142C2 (cg-RX-API-DMAC7.html) 1988-10-27

Similar Documents

Publication Publication Date Title
DE3005208C2 (cg-RX-API-DMAC7.html)
EP0752246A2 (de) Kappa-Opiate für entzündliche Darmerkrankungen
DE69908421T2 (de) Pharmazeutische zusammensetzung enthaltend eine kombination der dextro- und laevo-isomeren von sotalol
DE69110779T2 (de) Schilddrüsenhormone zur kardialen behandlung.
DE69937574T2 (de) Verwendung des pharmazeutischen präparates "histochrome" zur behandlung des akuten herzinfarkts und ischämischer herzerkrankungen
DE3234537C2 (de) Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionatdihydrat zur Behandlung kardiovaskulärer Erkrankungen
DE112013002717T5 (de) Induktion von Arteriogenese mit einem NO (Stickstoffmonoxid)-Donor
EP0212310B1 (de) Verwendung von Probucol zur Herstellung eines Arzneimittels für die Behandlung von Herzarrhythmie
DE3035480A1 (de) Pharmazeutische zusammensetzung zur behandlung von herzstoerungen
DE3789579T2 (de) Verwendung von Probucol zur Prävention und Behandlung von Herzkrankheiten.
DE3314142A1 (de) Mittel zur behandlung von myokardinfarkt
DE68908404T2 (de) Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens.
DE2658500A1 (de) Pharmazeutische praeparate mit kardioprotektiver wirkung
EP0649652B1 (de) Verwendung grenzwertig wirksamer Arzneiformen mit Betablockern
DE69919789T2 (de) Loratadin zur Verwendung als Antiarrhythmikum
DE3419067C2 (cg-RX-API-DMAC7.html)
DE1617336C2 (de) Arzneimittel gegen Angina pectoris
WO2004083157A1 (de) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen
EP0305902B1 (de) Arzneimittel
US3849570A (en) Method of treating cardiac arrhythmia with 2-(2'-diethylaminoethyl)-3-phenyl-phthalimidine and its salts
EP0007412B1 (de) Verwendung von 2-(N-(2,6-Dichlorphenyl)-N-allyl-amino)-imidazolin-(2) zur Herstellung von bradykarden Arzneimitteln
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE4035226A1 (de) Verwendung eines als muscarinagonist wirkenden mittels zur praevention und behandlung ventrikulaerer arrhytmie
EP0525537B1 (de) Verwendung von 1,4-Dihydropyridinen zur Herstellung eines Arzneimittels, zur Behandlung von Neuropathien, die durch Diabetes mellitus verursacht sind
DE3306128C2 (de) Pharmazeutische Verwendung von 2,4,6,8-Tetramethyl-2,4,6,8-tetraazobicyclo-[3,3,0]-oktandion-3,7

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee